Citations (98)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Ya-Li Hu & Ping-Ing Lee. (2021) Safety of Japanese encephalitis vaccines. Human Vaccines & Immunotherapeutics 17:11, pages 4259-4264.
Read now
Read now
Michael A. Stevenson. (2018) Geneva–Seattle collaboration in support of developing country vaccine manufacturing. Global Public Health 13:4, pages 426-441.
Read now
Read now
Peter Pushko, Igor S. Lukashevich, Scott C. Weaver & Irina Tretyakova. (2016) DNA-launched live-attenuated vaccines for biodefense applications. Expert Review of Vaccines 15:9, pages 1223-1234.
Read now
Read now
Xing Li, Shu-Juan Ma, Xie Liu, Li-Na Jiang, Jun-Hua Zhou, Yi-Quan Xiong, Hong Ding & Qing Chen. (2014) Immunogenicity and safety of currently available Japanese encephalitis vaccines: A systematic review. Human Vaccines & Immunotherapeutics 10:12, pages 3579-3593.
Read now
Read now
Sang-Im Yun & Young-Min Lee. (2014) Japanese encephalitis. Human Vaccines & Immunotherapeutics 10:2, pages 263-279.
Read now
Read now
Cindy Tamminga, Martha Sedegah, Santina Maiolatesi, Charlotte Fedders, Sharina Reyes, Anatalio Reyes, Carlos Vasquez, Yolanda Alcorta, Ilin Chuang, Michele Spring, Michael Kavanaugh, Harini Ganeshan, Jun Huang, Maria Belmonte, Esteban Abot, Arnel Belmonte, JoGlenna Banania, Fouzia Farooq, Jittawadee Murphy, Jack Komisar, Nancy O Richie, Jason Bennett, Keith Limbach, Noelle B Patterson, Joseph T Bruder, Meng Shi, Edward Miller, Sheetij Dutta, Carter Diggs, Lorraine A Soisson, Michael R Hollingdale, Judith E Epstein & Thomas L Richie. (2013) Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection. Human Vaccines & Immunotherapeutics 9:10, pages 2165-2177.
Read now
Read now
Eiji Konishi. (2013) Memory B cells: a proposed new immunological correlate for protective efficacy of Japanese encephalitis vaccine. Expert Review of Vaccines 12:8, pages 871-873.
Read now
Read now
Emmanuel Feroldi, Maria Rosario Capeding, Mark Boaz, Sophia Gailhardou, Claude Meric & Alain Bouckenooghe. (2013) Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children. Human Vaccines & Immunotherapeutics 9:4, pages 889-897.
Read now
Read now
Katrin Dubischar-Kastner & Niranjan Kanesa-thasan. (2012) Vaccinating against Japanese encephalitis virus: what have we learned from recent clinical trials?. Expert Review of Vaccines 11:10, pages 1159-1161.
Read now
Read now
Mario Lobigs & Michael S Diamond. (2012) Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex. Expert Review of Vaccines 11:2, pages 177-187.
Read now
Read now
Articles from other publishers (88)
Qiqi Xia, Yang Yang, Yan Zhang, Lujia Zhou, Xiaochun Ma, Changguang Xiao, Junjie Zhang, Zongjie Li, Ke Liu, Beibei Li, Donghua Shao, Yafeng Qiu, Jianchao Wei & Zhiyong Ma. (2023) Shift in dominant genotypes of Japanese encephalitis virus and its impact on current vaccination strategies. Frontiers in Microbiology 14.
Crossref
Crossref
Nihua Dong, Xinya Zhang, Hailong Zhang, Jiayang Zheng, Yafeng Qiu, Zongjie Li, Beibei Li, Ke Liu, Donghua Shao, Zhiyong Ma & Jianchao Wei. (2023) Genotype Change in Circulating JEV Strains in Fujian Province, China. Viruses 15:9, pages 1822.
Crossref
Crossref
Nadezhda Kuznetsova, Andrei Siniavin, Alexander Butenko, Victor Larichev, Alina Kozlova, Evgeny Usachev, Maria Nikiforova, Olga Usacheva, Alexey Shchetinin, Andrei Pochtovyi, Elena Shidlovskaya, Alina Odintsova, Elizaveta Belyaeva, Aleksander Voskoboinikov, Arina Bessonova, Lyudmila Vasilchenko, Galina Karganova, Vladimir Zlobin, Denis Logunov, Vladimir Gushchin & Alexander Gintsburg. (2023) Development and characterization of chimera of yellow fever virus vaccine strain and Tick-Borne encephalitis virus. PLOS ONE 18:5, pages e0284823.
Crossref
Crossref
L Preethi, M S Alina, Lakshmi Chandran, S Asvin, M Jagadeesan, T M Vijayakumar, V Chitra, Ashok Kumar Pandey, Mahendra M Reddy, Brij Ranjan Misra, Rajni Kant, Prudhvi Lal Bhukya, Gururaj Rao Deshpande, Priya Abraham, Gajanan Sapkal & Kamran Zaman. (2023) Duration of seroprotection of the live attenuated SA-14-14-2 Japanese encephalitis vaccine in children in India. Journal of Travel Medicine 30:2.
Crossref
Crossref
Bingan Wu, Zhongtian Qi & Xijing Qian. (2023) Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development. Viruses 15:4, pages 813.
Crossref
Crossref
John S. Mackenzie & Sai-Kit Lam. 2023. History of Arbovirology: Memories from the Field. History of Arbovirology: Memories from the Field
313
378
.
Kishore Kumar Pinapati, Reetika Tandon, Pratima Tripathi & Nidhi Srivastava. (2022)
Recent advances to overcome the burden of
Japanese encephalitis
: A zoonotic infection with problematic early detection
. Reviews in Medical Virology 33:1.
Crossref
Crossref
Leda R. Castilho, Nathalia R. Mattos, Wallace S. Abreu & Melissa L. E. Gutarra. (2022) Virus-like Particles (VLPs) as Important Tools for Flavivirus Vaccine Development. Biologics 2:4, pages 226-242.
Crossref
Crossref
Baldeep Khare & Richard J. Kuhn. (2022) The Japanese Encephalitis Antigenic Complex Viruses: From Structure to Immunity. Viruses 14:10, pages 2213.
Crossref
Crossref
Kiran Bala Sharma, Sudhanshu Vrati & Manjula Kalia. (2021) Pathobiology of Japanese encephalitis virus infection. Molecular Aspects of Medicine 81, pages 100994.
Crossref
Crossref
Clairissa A. Hansen & Alan D. T. Barrett. (2021) The Present and Future of Yellow Fever Vaccines. Pharmaceuticals 14:9, pages 891.
Crossref
Crossref
Sai Priyanka Bhimaneni & Anoop Kumar. (2021) Abscisic Acid, a Plant Hormone, Could be a Promising Candidate as an Anti-Japanese Encephalitis Virus (JEV) Agent. Anti-Infective Agents 18:4, pages 326-331.
Crossref
Crossref
Muhammad Naveed Anwar, Shuang Guo, Wang Xin, Muddassar Hameed, Abdul Wahaab, Xiaochun Ma, Aman Ullah Khan, Sajid Ur Rahman, Donghua Shao, Zongjie Li, Ke Liu, Beibei Li, Yafeng Qiu, Zhiyong Ma & Jianchao Wei. (2021) Adaptation of a live-attenuated genotype I Japanese encephalitis virus to vero cells is associated with mutations in structural protein genes. Virus Research 292, pages 198256.
Crossref
Crossref
Mark J. Bailey & Gene S. Tan. 2021. Zika Virus Impact, Diagnosis, Control, and Models. Zika Virus Impact, Diagnosis, Control, and Models
367
376
.
Yashpal Singh Malik, Arockiasamy Arun Prince Milton, Sandeep Ghatak & Souvik GhoshYashpal Singh Malik, Arockiasamy Arun Prince Milton, Sandeep Ghatak & Souvik Ghosh. 2021. Role of Birds in Transmitting Zoonotic Pathogens. Role of Birds in Transmitting Zoonotic Pathogens
25
37
.
Muhammad Naveed Anwar, Xin Wang, Muddassar Hameed, Abdul Wahaab, Chenxi Li, Mona Sharma, Linlin Pang, Muhammad Irfan Malik, Ke Liu, Beibei Li, Yafeng Qiu, Jianchao Wei & Zhiyong Ma. (2020) Phenotypic and Genotypic Comparison of a Live-Attenuated Genotype I Japanese Encephalitis Virus SD12-F120 Strain with Its Virulent Parental SD12 Strain. Viruses 12:5, pages 552.
Crossref
Crossref
Theodore C. Pierson & Michael S. Diamond. (2020) The continued threat of emerging flaviviruses. Nature Microbiology 5:6, pages 796-812.
Crossref
Crossref
Xin Wang, Shuang Guo, Muddassar Hameed, Junjie Zhang, Linlin Pang, Beibei Li, Yafeng Qiu, Ke Liu, Donghua Shao, Zhiyong Ma, Dengke Zhong, Jianchao Wei & Peng Li. (2020) Rapid differential detection of genotype I and III Japanese encephalitis virus from clinical samples by a novel duplex TaqMan probe-based RT-qPCR assay. Journal of Virological Methods 279, pages 113841.
Crossref
Crossref
Barnali Nath, Vandna, Hari Mohan Saini, Minakshi Prasad & Sachin Kumar. (2020) Evaluation of Japanese encephalitis virus E and NS1 proteins immunogenicity using a recombinant Newcastle disease virus in mice. Vaccine 38:7, pages 1860-1868.
Crossref
Crossref
Ha-Hyun Kim, Dong-Kun Yang, Miryeon Ji, Sang Kyu Lee & Bang-Hun Hyun. (2020) Genotype-specific neutralizing antibody titers against Japanese encephalitis virus genotypes 1 and 3 in horses immunized with a genotype 3 vaccine. Clinical and Experimental Vaccine Research 9:2, pages 102.
Crossref
Crossref
Yasuko ORBA, Hirofumi SAWA & Keita MATSUNO. (2020) Arthropod-borne viruses (arboviruses)節足動物媒介性ウイルス（アルボウイルス）. Uirusu 70:1, pages 3-14.
Crossref
Crossref
Jianchao Wei, Xin Wang, Junjie Zhang, Shuang Guo, Linlin Pang, Kun Shi, Ke Liu, Donghua Shao, Yafeng Qiu, Lihong Liu, Frederik Widén, Beibei Li & Zhiyong Ma. (2019) Partial cross-protection between Japanese encephalitis virus genotype I and III in mice. PLOS Neglected Tropical Diseases 13:8, pages e0007601.
Crossref
Crossref
David T. Williams, John S. MacKenzie & John Bingham. 2019. Diseases of Swine. Diseases of Swine
530
543
.
Rong Huang, Shengling Leng, Yalan Feng, Liping Tang, Lei Yuan & Jian Yang. (2019) Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14. Canadian Journal of Infectious Diseases and Medical Microbiology 2019, pages 1-7.
Crossref
Crossref
Reshma Kulkarni, Gajanan N. Sapkal, Himanshu Kaushal & Devendra T. Mourya. (2018) Japanese Encephalitis: A Brief Review on Indian Perspectives. The Open Virology Journal 12:1, pages 121-130.
Crossref
Crossref
Minhua Sun, Jiawen Dong, Linlin Li, Qiuyan Lin, Junying Sun, Zhicheng Liu, Haiyan Shen, Jianfeng Zhang, Tao Ren & Chunhong Zhang. (2018) Recombinant Newcastle disease virus (NDV) expressing Duck Tembusu virus (DTMUV) pre-membrane and envelope proteins protects ducks against DTMUV and NDV challenge. Veterinary Microbiology 218, pages 60-69.
Crossref
Crossref
Christian Stutzer, Sabine A. Richards, Mariette Ferreira, Samantha Baron & Christine Maritz-Olivier. (2018) Metazoan Parasite Vaccines: Present Status and Future Prospects. Frontiers in Cellular and Infection Microbiology 8.
Crossref
Crossref
Ki Wook Yun, Hoan Jong Lee, Ji Young Park, Hye-Kyung Cho, Yae-Jean Kim, Kyung-Hyo Kim, Nam Hee Kim, Young Jin Hong, Dong Ho Kim, Hwang Min Kim & Sung-Ho Cha. (2018) Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine. Vaccine 36:11, pages 1398-1404.
Crossref
Crossref
Ara Ko, Seo Ri Wui, Ji In Ryu, Hien Thi Thu Do, Yeon Jeong Lee, Soo Jeong Lim, Inmoo Rhee, Dae Im Jung, Jin-ah Park, Jung-ah Choi, Man Ki Song & Na Gyong Lee. (2017) Comparison of the adjuvanticity of two adjuvant formulations containing de-O-acylated lipooligosaccharide on Japanese encephalitis vaccine in mice. Archives of Pharmacal Research 41:2, pages 219-228.
Crossref
Crossref
Barney S. Graham & Nancy J. Sullivan. (2017) Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic. Nature Immunology 19:1, pages 20-28.
Crossref
Crossref
Scott B. Halstead, Susan L. Hills & Katrin Dubischar. 2018. Plotkin's Vaccines. Plotkin's Vaccines
511
548.e12
.
Stefan W. Metz & Gorben P. Pijlman. 2018. Chikungunya and Zika Viruses. Chikungunya and Zika Viruses
347
365
.
Devi Shankar Suman, Kshitij Chandel, Ary Faraji, Randy Gaugler & Kailash Chandra. 2018. Mosquito-borne Diseases. Mosquito-borne Diseases
235
279
.
Kaitlyn M Morabito & Barney S Graham. (2017) Zika Virus Vaccine Development. The Journal of Infectious Diseases 216:suppl_10, pages S957-S963.
Crossref
Crossref
Brian Nickols, Irina Tretyakova, Alexander Tibbens, Elena Klyushnenkova & Peter Pushko. (2017) Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice. Virology 512, pages 66-73.
Crossref
Crossref
Ashok Munjal, Rekha Khandia, Ruchi Tiwari, Sandip Chakrabort, Kumaragurubaran Karthik & Kuldeep Dhama. (2017) Advances in Designing and Developing Vaccines Against Zika Virus. International Journal of Pharmacology 13:7, pages 667-676.
Crossref
Crossref
Hongliang ChuZhiming WuHongna ChenChunxiao LiXiaoxia GuoRan LiuGang WangMinghao ZhouTongyan Zhao. (2017)
Japanese Encephalitis Virus Infection Rate and Detection of Genotype I From
Culex tritaeniorhynchus
Collected From Jiangsu, China
. Vector-Borne and Zoonotic Diseases 17:7, pages 503-509.
Crossref
Crossref
Cinnamon Hardee, Lirio Arévalo-Soliz, Benjamin Hornstein & Lynn Zechiedrich. (2017) Advances in Non-Viral DNA Vectors for Gene Therapy. Genes 8:2, pages 65.
Crossref
Crossref
Dan H. Barouch, Stephen J. Thomas & Nelson L. Michael. (2017) Prospects for a Zika Virus Vaccine. Immunity 46:2, pages 176-182.
Crossref
Crossref
Rohan KeshwaraReed F. Johnson & Matthias J. Schnell. (2017) Toward an Effective Ebola Virus Vaccine. Annual Review of Medicine 68:1, pages 371-386.
Crossref
Crossref
Sang-Im Yun, Byung-Hak Song, Irina A. Polejaeva, Christopher J. Davies, Kenneth L. White & Young-Min Lee. (2016) Comparison of the live-attenuated Japanese encephalitis vaccine SA14 -14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo. Journal of General Virology 97:10, pages 2575-2591.
Crossref
Crossref
Theodore C. Pierson & Barney S. Graham. (2016) Zika Virus: Immunity and Vaccine Development. Cell 167:3, pages 625-631.
Crossref
Crossref
Byung-Chul Kim, Do-Keun Kim, Hyung-Jin Kim, Seung-Hwa Hong, Yeonhee Kim, Jong-Mi Lim, JiYoung Hong, Cheol-Hee Kim, Yong-Keun Park & Jaeok Kim. (2016) A collaborative study of an alternative in vitro potency assay for the Japanese encephalitis vaccine. Virus Research 223, pages 190-196.
Crossref
Crossref
Katie J Ewer, Teresa Lambe, Christine S Rollier, Alexandra J Spencer, Adrian VS Hill & Lucy Dorrell. (2016) Viral vectors as vaccine platforms: from immunogenicity to impact. Current Opinion in Immunology 41, pages 47-54.
Crossref
Crossref
Brian E Dawes, Claire A Smalley, Bethany L Tiner, David WC Beasley, Gregg N Milligan, Lisa M Reece, Joachim Hombach & Alan DT Barrett. (2016) Research and development of Zika virus vaccines. npj Vaccines 1:1.
Crossref
Crossref
Hyo-Jung ParkHae Li KoSeo-Yeon JungHan-Byeol JoJae-Hwan Nam. (2016) The Characteristics of RNA Vaccine; its Strengths and Weaknesses. Journal of Bacteriology and Virology 46:3, pages 115.
Crossref
Crossref
Ping Qian, Xianwei Zhi, Bo Wang, Huawei Zhang, Huanchun Chen & Xiangmin Li. (2015) Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І. Virology Journal 12:1.
Crossref
Crossref
Ki Wook Yun, Hoan Jong Lee, Jin Han Kang, Byung Wook Eun, Yae-Jean Kim, Kyung-Hyo Kim, Nam Hee Kim, Young Jin Hong, Dong Ho Kim, Hwang Min Kim & Sung-Ho Cha. (2015) Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial. BMC Infectious Diseases 15:1.
Crossref
Crossref
Yi-Chin Fan, Hsien-Chung Chiu, Li-Kuang Chen, Gwong-Jen J. Chang & Shyan-Song Chiou. (2015) Formalin Inactivation of Japanese Encephalitis Virus Vaccine Alters the Antigenicity and Immunogenicity of a Neutralization Epitope in Envelope Protein Domain III. PLOS Neglected Tropical Diseases 9:10, pages e0004167.
Crossref
Crossref
Mélissanne de Wispelaere, Meret Ricklin, Philippe Souque, Marie-Pascale Frenkiel, Sylvie Paulous, Obdulio Garcìa-Nicolàs, Artur Summerfield, Pierre Charneau & Philippe Desprès. (2015) A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs. PLOS Neglected Tropical Diseases 9:10, pages e0004081.
Crossref
Crossref
Anit Singh, Monjori Mitra, Gadey Sampath, P. Venugopal, J. Venkateswara Rao, B. Krishnamurthy, Mukesh Kumar Gupta, S. Sri Krishna, B. Sudhakar, N. Bhuvaneswara Rao, Yashpal Kaushik, K. Gopinathan, Nagendra R. Hegde, Milind M. Gore, V. Krishna Mohan & Krishna M. Ella. (2015) A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains. Journal of Infectious Diseases 212:5, pages 715-725.
Crossref
Crossref
Claire L. Jeffries & Thomas Walker. (2015) The Potential Use of Wolbachia-Based Mosquito Biocontrol Strategies for Japanese Encephalitis. PLOS Neglected Tropical Diseases 9:6, pages e0003576.
Crossref
Crossref
Gregory D. Gromowski, Cai-Yen Firestone & Stephen S. Whitehead. (2015) Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice. Journal of Virology 89:12, pages 6328-6337.
Crossref
Crossref
Jin-Kyoung Kim, Jeong-Min Kim, Byung-Hak Song, Sang-Im Yun, Gil-Nam Yun, Sung-June Byun & Young-Min Lee. (2015) Profiling of Viral Proteins Expressed from the Genomic RNA of Japanese Encephalitis Virus Using a Panel of 15 Region-Specific Polyclonal Rabbit Antisera: Implications for Viral Gene Expression. PLOS ONE 10:4, pages e0124318.
Crossref
Crossref
Xiaohong Jiang, Tim J. Dalebout, Igor S. Lukashevich, Peter J. Bredenbeek & David Franco. (2015) Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone. Journal of General Virology 96:4, pages 804-814.
Crossref
Crossref
Stephen S. Whitehead, José Bustos-Arriaga, Cai-Yen Firestone & Gregory D. Gromowski. (2015) Genetic and Phenotypic Properties of Vero Cell-Adapted Japanese Encephalitis Virus SA14-14-2 Vaccine Strain Variants and a Recombinant Clone, Which Demonstrates Attenuation and Immunogenicity in Mice. The American Journal of Tropical Medicine and Hygiene 92:1, pages 98-107.
Crossref
Crossref
Theodore C. Pierson & Michael S. Diamond. 2015. The Molecular Basis of Viral Infection. The Molecular Basis of Viral Infection
141
166
.
Stephen J. Thomas, Timothy P. Endy, Alan L. Rothman & Alan D. Barrett. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
1881
1903.e6
.
Rong-Hong Hua, Ye-Nan Li, Zhen-Shi Chen, Li-Ke Liu, Hong Huo, Xiao-Lei Wang, Li-Ping Guo, Nan Shen, Jing-Fei Wang & Zhi-Gao Bu. (2014) Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate. BMC Biotechnology 14:1.
Crossref
Crossref
Matthew Bonaparte, Bashir Dweik, Emmanuel Feroldi, Claude Meric, Alain Bouckenooghe, Stephen Hildreth, Branda Hu, Sutee Yoksan & Mark Boaz. (2014) Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India. BMC Infectious Diseases 14:1.
Crossref
Crossref
Carlo Amorin Daep, Jorge L. Muñoz-Jordán & Eliseo Alberto Eugenin. (2014) Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus. Journal of NeuroVirology 20:6, pages 539-560.
Crossref
Crossref
Salah Uddin Khan, Henrik Salje, A. Hannan, Md. Atiqul Islam, A. A. Mamun Bhuyan, Md. Ariful Islam, M. Ziaur Rahman, Nazmun Nahar, M. Jahangir Hossain, Stephen P. Luby & Emily S. Gurley. (2014) Dynamics of Japanese Encephalitis Virus Transmission among Pigs in Northwest Bangladesh and the Potential Impact of Pig Vaccination. PLoS Neglected Tropical Diseases 8:9, pages e3166.
Crossref
Crossref
Sang-Im Yun, Byung-Hak Song, Jin-Kyoung Kim, Gil-Nam Yun, Eun-Young Lee, Long Li, Richard J. Kuhn, Michael G. Rossmann, John D. Morrey & Young-Min Lee. (2014) A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA14-14-2 Virus: A Conserved Single Amino Acid in the ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice. PLoS Pathogens 10:7, pages e1004290.
Crossref
Crossref
Swati Mukherjee, Kimberly A. Dowd, Carolyn J. Manhart, Julie E. Ledgerwood, Anna P. Durbin, Stephen S. Whitehead & Theodore C. Pierson. (2014) Mechanism and Significance of Cell Type-Dependent Neutralization of Flaviviruses. Journal of Virology 88:13, pages 7210-7220.
Crossref
Crossref
Gregory D. Gromowski, Cai-Yen Firestone, Christopher T. Hanson & Stephen S. Whitehead. (2014) Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4. Vaccine 32:25, pages 3010-3018.
Crossref
Crossref
Chiaki Miyazaki, Kenji Okada, Takao Ozaki, Mizuo Hirose, Kaneshige Iribe, Hiroyuki Yokote, Yuji Ishikawa, Takehiro Togashi & Kohji Ueda. (2014) Phase III Clinical Trials Comparing the Immunogenicity and Safety of the Vero Cell-Derived Japanese Encephalitis Vaccine Encevac with Those of Mouse Brain-Derived Vaccine by Using the Beijing-1 Strain. Clinical and Vaccine Immunology 21:2, pages 188-195.
Crossref
Crossref
Yun Young GoUdeni B. R. BalasuriyaChong-kyo Lee. (2014) Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses. Clinical and Experimental Vaccine Research 3:1, pages 58.
Crossref
Crossref
Xiao-Feng Li, Yong-Qiang Deng, Hui-Qiang Yang, Hui Zhao, Tao Jiang, Xue-Dong Yu, Shi-Hua Li, Qing Ye, Shun-Ya Zhu, Hong-Jiang Wang, Yu Zhang, Jie Ma, Yong-Xin Yu, Zhong-Yu Liu, Yu-Hua Li, E-De Qin, Pei-Yong Shi & Cheng-Feng Qin. (2013) A Chimeric Dengue Virus Vaccine using Japanese Encephalitis Virus Vaccine Strain SA14-14-2 as Backbone Is Immunogenic and Protective against Either Parental Virus in Mice and Nonhuman Primates. Journal of Virology 87:24, pages 13694-13705.
Crossref
Crossref
Shi-Hua Li, Xiao-Feng Li, Hui Zhao, Yong-Qiang Deng, Xue-Dong Yu, Shun-Ya Zhu, Tao Jiang, Qing Ye, E-De Qin & Cheng-Feng Qin. (2013) Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2. Virology Journal 10:1.
Crossref
Crossref
Dennis W. Trent, Philip Minor, Teeranart Jivapaisarnpong & Jinho Shin. (2013) WHO working group on the quality, safety and efficacy of Japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21–23 February 2012. Biologicals 41:6, pages 450-457.
Crossref
Crossref
Christopher L. Parks, Louis J. Picker & C. Richter King. (2013) Development of replication-competent viral vectors for HIV vaccine delivery. Current Opinion in HIV and AIDS 8:5, pages 402-411.
Crossref
Crossref
Ravi Kant Upadhyay. (2013) Japanese Encephalitis Virus Generated Neurovirulence, Antigenicity, and Host Immune Responses. ISRN Virology 2013, pages 1-24.
Crossref
Crossref
Shi-Hua Li, Hongping Dong, Xiao-Feng Li, Xuping Xie, Hui Zhao, Yong-Qiang Deng, Xiao-Yu Wang, Qing Ye, Shun-Ya Zhu, Hong-Jiang Wang, Bo Zhang, Qi-Bin Leng, Roland Zuest, E-De Qin, Cheng-Feng Qin & Pei-Yong Shi. (2013)
Rational Design of a Flavivirus Vaccine by Abolishing Viral RNA 2′-
O
Methylation
. Journal of Virology 87:10, pages 5812-5819.
Crossref
Crossref
Yi-Chin Fan, Jo-Mei Chen, Yi-Ying Chen, Jen-Wei Lin & Shyan-Song Chiou. (2013) Reduced neutralizing antibody titer against genotype I virus in swine immunized with a live-attenuated genotype III Japanese encephalitis virus vaccine. Veterinary Microbiology 163:3-4, pages 248-256.
Crossref
Crossref
Maximilian Larena, Natalie A. Prow, Roy A. Hall, Nikolai Petrovsky & Mario Lobigs. (2013)
JE-ADVAX Vaccine Protection against Japanese Encephalitis Virus Mediated by Memory B Cells in the Absence of CD8
+
T Cells and Pre-Exposure Neutralizing Antibody
. Journal of Virology 87:8, pages 4395-4402.
Crossref
Crossref
Ilin Chuang, Martha Sedegah, Susan Cicatelli, Michele Spring, Mark Polhemus, Cindy Tamminga, Noelle Patterson, Melanie Guerrero, Jason W. Bennett, Shannon McGrath, Harini Ganeshan, Maria Belmonte, Fouzia Farooq, Esteban Abot, Jo Glenna Banania, Jun Huang, Rhonda Newcomer, Lisa Rein, Dianne Litilit, Nancy O. Richie, Chloe Wood, Jittawadee Murphy, Robert Sauerwein, Cornelus C. Hermsen, Andrea J. McCoy, Edwin Kamau, James Cummings, Jack Komisar, Awalludin Sutamihardja, Meng Shi, Judith E. Epstein, Santina Maiolatesi, Donna Tosh, Keith Limbach, Evelina Angov, Elke Bergmann-Leitner, Joseph T. Bruder, Denise L. Doolan, C. Richter King, Daniel Carucci, Sheetij Dutta, Lorraine Soisson, Carter Diggs, Michael R. Hollingdale, Christian F. Ockenhouse & Thomas L. Richie. (2013) DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity. PLoS ONE 8:2, pages e55571.
Crossref
Crossref
Scott B. Halstead, Julie Jacobson & Katrin Dubischar-Kastner. 2013. Vaccines. Vaccines
312
351
.
F.X. Heinz & Karin Stiasny. (2012) Flaviviruses and their antigenic structure. Journal of Clinical Virology 55:4, pages 289-295.
Crossref
Crossref
Suvasini Sharma, Devendra Mishra, Satinder Aneja, Rashmi Kumar, Amita Jain & Vipin M. Vashishtha. (2012) Consensus guidelines on evaluation and management of suspected acute viral encephalitis in children in India. Indian Pediatrics 49:11, pages 897-910.
Crossref
Crossref
Qing Ye, Xiao-Feng Li, Hui Zhao, Shi-Hua Li, Yong-Qiang Deng, Rui-Yuan Cao, Ke-Yu Song, Hong-Jiang Wang, Rong-Hong Hua, Yong-Xin Yu, Xi Zhou, E-De Qin & Cheng-Feng Qin. (2012) A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1’ formation and contributes to attenuation. Journal of General Virology 93:9, pages 1959-1964.
Crossref
Crossref
Zundong Yin, Garrett R. Beeler Asay, Li Zhang, Yixing Li, Shuyan Zuo, Yvan J. Hutin, Guijun Ning, Hardeep S. Sandhu, Lisa Cairns & Huiming Luo. (2012) An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China. Vaccine 30:37, pages 5569-5577.
Crossref
Crossref
Byung-Hak Song, Gil-Nam Yun, Jin-Kyoung Kim, Sang-Im Yun & Young-Min Lee. (2012) Biological and genetic properties of SA14-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans. Journal of Microbiology 50:4, pages 698-706.
Crossref
Crossref
Reshma Kulkarni, Gajanan Sapkal, Lata Mahishi, Pratip Shil & Milind M. Gore. (2012) Design and characterization of polytope construct with multiple B and TH epitopes of Japanese encephalitis virus. Virus Research 166:1-2, pages 77-86.
Crossref
Crossref
Franz X. Heinz & Karin Stiasny. (2012) Flaviviruses and flavivirus vaccines. Vaccine 30:29, pages 4301-4306.
Crossref
Crossref
Kamal Desai, L. Coudeville & F. Bailleux. (2012) Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine. Vaccine 30:15, pages 2510-2515.
Crossref
Crossref
Akiko Kikukawa, Yasuyuki Gomi, Masateru Akechi, Toshiyuki Onishi, Sadao Manabe, Junko Namazue, Isao Fuke, Toyokazu Ishikawa, Yoshinobu Okuno & Shigeharu Ueda. (2012) Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated). Vaccine 30:13, pages 2329-2335.
Crossref
Crossref
Thananya Thongtan, Chutima Thepparit & Duncan R. Smith. (2012) The Involvement of Microglial Cells in Japanese Encephalitis Infections. Clinical and Developmental Immunology 2012, pages 1-7.
Crossref
Crossref
Evandro R. Winkelmann, Douglas G. Widman, Ryosuke Suzuki & Peter W. Mason. (2011) Analyses of mutations selected by passaging a chimeric flavivirus identify mutations that alter infectivity and reveal an interaction between the structural proteins and the nonstructural glycoprotein NS1. Virology 421:2, pages 96-104.
Crossref
Crossref